Cargando…

RARE-32. Phase 0 and feasibility single-institution clinical trial of intravenous tocilizumab for adamantinomatous craniopharyngioma

BACKGROUND: Adamantinomatous craniopharyngioma (ACP) is a devastating skull-base tumor believed to derive from epithelial remnants of the primordial craniopharyngeal duct (Rathke’s pouch), which gives rise to the anterior pituitary gland. ACP lacks medical antitumor therapies. Current standard thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorris, Kathleen, Mettetal, Ashley, Dahl, Nathan, Hemenway, Molly, Winzent-Oonk, Shelby, Prince, Eric, Vijmasi, Trinka, McWilliams, Jennifer, Jordan, Kimberly, Mirsky, David, Hoffman, Lindsey, Hankinson, Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Craniopharyngioma and Rare Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165090/ http://dx.doi.org/10.1093/neuonc/noac079.057

Ejemplares similares

RARE-10. ADAMANTINOMATOUS CRANIOPHARYNGIOMA RESIDES OUTSIDE THE BLOOD BRAIN BARRIER
por: Prince, Eric, et al.
Publicado: (2020)

RARE-08. CYST FLUID CYTOKINES MAY PROMOTE EPITHELIAL-TO-MESENCHYMAL TRANSITION IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Vijmasi, Trinka, et al.
Publicado: (2020)

RARE-07. THE LANDSCAPE OF GENOMIC ALTERATIONS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS
por: Khadka, Prasidda, et al.
Publicado: (2020)

RARE-11. QUANTITATIVE MR IMAGING FEATURES ASSOCIATED WITH UNIQUE TRANSCRIPTIONAL CHARACTERISTICS IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA: A POTENTIAL GUIDE FOR THERAPY
por: Mirsky, David, et al.
Publicado: (2020)

RARE-22 Characterizing the landscape of structural variants in adamantinomatous craniopharyngioma
por: Jomaa, Danny, et al.
Publicado: (2022)

RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
por: Trudeau, Tammy, et al.
Publicado: (2022)

RARE-63. CYST WALL OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA CONTAINS TUMOR CELLS THAT COULD LEAD TO RECURRENCE AFTER SURGERY
por: Zhao, Chuan, et al.
Publicado: (2020)

RARE-19. NETWORK AND DEEP LEARNING INFERENCE IN SINGLE CELL RNA SEQUENCING REVEAL DETAILED TRANSCRIPTIONAL SIGNATURES CONGRUENT WITH MOLECULAR UNDERSTANDING OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Prince, Eric, et al.
Publicado: (2021)

Adamantinomatous craniopharyngioma associated with a compromised blood–brain barrier: patient series
por: Prince, Eric W., et al.
Publicado: (2021)

RARE-16. Differential expression of miRNAs in adamantinomatous craniopharynngioma reveals dysregulation of pathogenic pathways
por: Apps, John
Publicado: (2022)

RARE-13. Clinical management and functional and survival outcomes in pediatric craniopharyngioma, a patient and family perspective
por: Marshall, Emily, et al.
Publicado: (2022)

RARE-02.RE-IRRADIATION FOR RECURRENT CRANIOPHARYNGIOMA
por: Foran, Sarah, et al.
Publicado: (2020)

RARE-08. Profiling of recurrent adamantinomatous cranionpharyngioma confirms the activation of the MAPK pathway and identifies copy number aberrations in relapsed tumours
por: Apps, John, et al.
Publicado: (2022)

RARE-17. Multi-institutional craniopharyngioma cohort highlights need for more comprehensive data collection on comorbidities and quality of life
por: Marshall, Emily, et al.
Publicado: (2022)

RARE-06. OPTIMIZATION OF PROTON RADIATION THERAPY FOR GIANT CRANIOPHARYNGIOMAS
por: Flores, Valerie Cruz, et al.
Publicado: (2020)

RARE-12. VASCULOPATHY IN PEDIATRIC CRANIOPHARYNGIOMA PATIENTS TREATED WITH SURGERY AND RADIOTHERAPY
por: Lucas, John, et al.
Publicado: (2020)

RARE-11. 60 years single centre experience of craniopharyngioma management
por: Rodrigues, Beryl, et al.
Publicado: (2022)

RARE-27. DOUBLE MUTATIONS: DIFFERENT GERMLINE AND TUMOR MUTATIONS LEAD TO POOR OUTCOMES
por: Hemenway, Molly, et al.
Publicado: (2020)

RARE-03. AGGRESSIVE RESECTION FOR PEDIATRIC CRANIOPHARYNGIOMAS VIA ENDOSCOPIC ENDONASAL APPROACH
por: Morisako, Hiroki, et al.
Publicado: (2020)

RARE-04. INTELLECTUAL DEVELOPMENT IN CHILDREN WITH PEDIATRIC CRANIOPHARYNGIOMA AFTER TUMOR REMOVAL
por: Oyoshi, Tatsuki, et al.
Publicado: (2020)

RARE-60. PREGNANCIES AFTER CHILDHOOD CRANIOPHARYNGIOMA – RESULTS OF KRANIOPHARYNGEOM 2000/2007
por: Sowithayasakul, Panjarat, et al.
Publicado: (2020)

RARE-62. VISUAL FUNCTION IN CHILDREN WITH CRANIOPHARYNGIOMA AT DIAGNOSIS: A SYSTEMATIC REVIEW
por: Nuijts, Myrthe, et al.
Publicado: (2020)

RARE-28. The use of subcutaneous interferon in patients with craniopharyngioma: an institutional retrospective review
por: Patil, Prabhumallikarjun, et al.
Publicado: (2022)

RARE-01. MANAGEMENT AND OUTCOMES OF PAEDIATRIC CRANIOPHARYNGIOMA: A 15-YEAR EXPERIENCE IN SINGAPORE
por: Lim, Mervyn Jun Rui, et al.
Publicado: (2020)

RARE-01. Cerebral infarction in childhood-onset craniopharyngioma patients: results of KRANIOPHARYNGEOM 2007
por: Boekhoff, Svenja, et al.
Publicado: (2022)

RARE-09. PRESERVATION OF ENDOCRINE FUNCTION AFTER OMMAYA RESERVOIR INSERTION IN CHILDREN WITH CYSTIC CRANIOPHARYNGIOMA
por: Lohkamp, Laura-Nanna, et al.
Publicado: (2020)

RARE-23. Preservation of endocrine function after Ommaya reservoir insertion in children with cystic craniopharyngioma
por: Lohkamp, Laura-Nanna, et al.
Publicado: (2022)

RARE-18. Pediatric craniopharyngioma; single center experience in 246 cases with different management modalities
por: El Beltagy, Mohamed, et al.
Publicado: (2022)

RARE-59. CARDIAC REMODELING IN PATIENTS WITH CHILDHOOD-ONSET CRANIOPHARYNGIOMA – RESULTS OF HIT-ENDO AND KRANIOPHARYNGEOM 2000/2007
por: Sowithayasakul, Panjarat, et al.
Publicado: (2020)

RARE-05. Legal degree of disability in childhood-craniopharyngioma survivors during long-term follow-up – results of the HIT-ENDO study
por: Boekhoff, Svenja, et al.
Publicado: (2022)

RARE-09. Treatment of childhood-onset craniopharyngioma patients using proton beam therapy versus photon-based radiation therapy in the prospective KRANIOPHARYNGEOM 2007 trial
por: Friedrich, Carsten, et al.
Publicado: (2022)

RARE-32. PEDIATRIC METASTATIC SKULL BASE CHORDOMA WITH TP53 MUTATION – A CASE REPORT AND REVIEW OF THE LITERATURE
por: Shimada, Akira, et al.
Publicado: (2020)

RARE-37. NOONAN SYNDROME AND GLIONEURONAL TUMORS: A CENTRAL NERVOUS SYSTEM CANCER PREDISPOSITION ASSOCIATION?
por: Shatara, Margaret, et al.
Publicado: (2020)

RARE-17. SURVIVAL BENEFIT FOR INDIVIDUALS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME AND BRAIN TUMORS WHO UNDERGO SURVEILLANCE PROTOCOL. A REPORT FROM THE INTERNATIONAL REPLICATION REPAIR CONSORTIUM
por: Ercan, Ayse Bahar, et al.
Publicado: (2020)

RARE-26. RETROSPECTIVE ANALYSIS OF PEDIATRIC CHOROID PLEXUS TUMORS
por: Nakano, Yoshiko, et al.
Publicado: (2020)

RARE-56. PERITONEAL SEEDING OF A DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR IN A CHILD
por: Messiaen, Julie, et al.
Publicado: (2020)

RARE-25. RETINAL ASTROCYTOMA mTOR INHIBITOR THERAPY IN TUBEROUS SCLEROSIS MOSAICISM
por: Evans, Naomi, et al.
Publicado: (2020)

RARE-43. FAVORABLE OUTCOME OF A YOUNG GIRL WITH RECURRENT METASTATIC PINEOBLASTOMA ASSOCIATED WITH A DICER1 MUTATION
por: Rossi, Adam, et al.
Publicado: (2020)

RARE-50. TREATMENT RESPONSE OF CNS HIGH-GRADE NEUROEPITHELIAL TUMORS WITH MN1 ALTERATION
por: Baroni, Lorena V, et al.
Publicado: (2020)

RARE-22. GERMLINE PATHOGENIC VARIANT c.1552G>A;p.E518K IN DGCR8 CONFERS SUSCEPTIBILITY FOR SCHWANNOMATOSIS AND THYROID TUMORS
por: Chong, Anne-Sophie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fusrgk6ietc1vd1d3ppo4hu0h9